GSK3B and type 2 diabetes mellitus: The activation and the nuclear accumulation of Fyn are partially stimulated by glycogen synthase kinase‐3β (GSK‐3β) (Zhang et al., 2012), which reduces insulin sensitivity and hepatic glycogen storage in type 2 diabetes (Gao et al., 2011).